Strategy Asset Managers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,391
| Closed | -$206K | – | 267 |
|
|
2026
Q1 | $206K | Buy |
+3,391
| New | +$198K | 0.03% | 258 |
|
|
2024
Q3 | – | Sell |
-10,744
| Closed | -$687K | – | 253 |
|
|
2024
Q2 | $687K | Buy |
+10,744
| New | +$481K | 0.15% | 114 |
|
|
2023
Q3 | – | Sell |
-10,744
| Closed | -$687K | – | 232 |
|
|
2023
Q2 | $687K | Buy |
10,744
+685
| +7% | +$45.9K | 0.15% | 114 |
|
|
2023
Q1 | $697K | Buy |
+10,059
| New | +$709K | 0.17% | 102 |
|
|
2019
Q2 | – | Sell |
-82,625
| Closed | -$3.94M | – | 129 |
|
|
2019
Q1 | $3.94M | Sell |
82,625
-13,856
| -14% | -$690K | 0.89% | 29 |
|
|
2018
Q4 | $5.01M | Sell |
96,481
-21,299
| -18% | -$1.14M | 1.22% | 30 |
|
|
2018
Q3 | $7.31M | Sell |
117,780
-13,923
| -11% | -$826K | 1.49% | 25 |
|
|
2018
Q2 | $7.29M | Sell |
131,703
-9
| -0% | -$486 | 1.54% | 26 |
|
|
2018
Q1 | $8.33M | Buy |
131,712
+10,190
| +8% | +$656K | 1.81% | 23 |
|
|
2017
Q4 | $7.45M | Buy |
121,522
+17,337
| +17% | +$1.08M | 1.46% | 25 |
|
|
2017
Q3 | $6.64M | Sell |
104,185
-2,782
| -3% | -$162K | 1.36% | 25 |
|
|
2017
Q2 | $5.96M | Sell |
106,967
-12,080
| -10% | -$657K | 1.23% | 29 |
|
|
2017
Q1 | $6.47M | Sell |
119,047
-12,777
| -10% | -$701K | 1.41% | 27 |
|
|
2016
Q4 | $6.42M | Sell |
131,824
-3,104
| -2% | -$170K | 1.4% | 27 |
|
|
2016
Q3 | $7.28M | Buy |
134,928
+4,983
| +4% | +$320K | 1.63% | 25 |
|
|
2016
Q2 | $9.56M | Sell |
129,945
-13,096
| -9% | -$925K | 2.17% | 12 |
|
|
2016
Q1 | $9.14M | Sell |
143,041
-35,175
| -20% | -$2.22M | 2.08% | 17 |
|
|
2015
Q4 | $12.3M | Sell |
178,216
-5,988
| -3% | -$396K | 2.79% | 4 |
|
|
2015
Q3 | $10.9M | Sell |
184,204
-2,858
| -2% | -$181K | 2.62% | 4 |
|
|
2015
Q2 | $12.4M | Sell |
187,062
-2,835
| -1% | -$187K | 2.78% | 4 |
|
|
2015
Q1 | $12.2M | Sell |
189,897
-16,977
| -8% | -$1.06M | 2.67% | 3 |
|
|
2014
Q4 | $12.2M | Sell |
206,874
-3,421
| -2% | -$193K | 2.57% | 6 |
|
|
2014
Q3 | $10.8M | Buy |
210,295
+5,438
| +3% | +$272K | 2.35% | 11 |
|
|
2014
Q2 | $9.94M | Buy |
204,857
+184,340
| +898% | +$9.08M | 2.12% | 18 |
|
|
2014
Q1 | $1.07M | Sell |
20,517
-1,465
| -7% | -$78K | 0.23% | 73 |
|
|
2013
Q4 | $1.17M | Buy |
21,982
+15
| +0.1% | +$764 | 0.26% | 74 |
|
|
2013
Q3 | $1.02M | Buy |
21,967
+1,289
| +6% | +$56.6K | 0.24% | 76 |
|
|
2013
Q2 | $924K | Buy |
+20,678
| New | +$898K | 0.22% | 78 |
|
Other funds holding BMY
Strategy Asset Managers's BMY Position: Q2 2026 in Review
Strategy Asset Managers sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 3,391 shares — an estimated $206K sold.
Strategy Asset Managers first reported a position in BMY in Q2 2013 and held it in 28 quarters. The position peaked at $12.4M in Q2 2015. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Strategy Asset Managers reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Strategy Asset Managers sold 3,391 Bristol-Myers Squibb shares in Q2 2026, an estimated $206K.
- Strategy Asset Managers first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 28 quarters.
- Strategy Asset Managers's Bristol-Myers Squibb position peaked at $12.4M in Q2 2015.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Strategy Asset Managers's 13F filing for Q2 2026, filed 14 Aug 2026.